- Email: [email protected]
Neozyme International enters into distribution agreement in NY
F O C U S reported turnover of $1.497 M ($1.177 M in 3Q 2001), R&D costs of $3.489 M ($3.804 M), an operating loss of $4.176 M (operating loss of $6.288 M), a net loss of $3.896 M (net loss of $5.860 M), and a loss per share of $0.22 (loss per share $0.37). For the nine months to 30 Sep 2002 Catalytica Energy Systems Inc has reported turnover of $3.369 M ($4.835 M in Jan-Sep 2001), R&D costs of $10.548 M ($11.412 M), an operating loss of $15.413 M (operating loss of $13.919 M), a net loss of $14.443 M (net loss of $12.456 M), and a loss per share of $0.82 (loss per share $0.90).There is a discussion of the results. Catalytica 3Q Results 2002, 4 Nov 2002, 1-3 (Catalytica Energy Systems Inc, 430 Ferguson Drive, Bldg 3, Mountain View, CA 94043, USA. Tel: +1 650 960 3000. Website: http://www.catalyticaenergy.com)
Danisco and Direvo sign enzyme development collaboration Direvo Biotech AG (Direvo) and Danisco A/S announced the signing of a collaboration agreement under which both parties will develop an industrial enzyme. Under the terms of the agreement, Danisco will obtain worldwide exclusive rights to commercialize the products developed under this collaboration. In return, Direvo will receive R&D funding, milestone payments, and royalties on future product sales. Direvo Biotech AG, based in Cologne, is a leading company in screeningbased directed evolution and applies its integrated proprietary technologies to the development of better biopharmaceuticals and improved industrial enzymes. Danisco A/S develops and produces functional ingredients, sweeteners, and sugar. Press release from Direvo Biotech AG, Nattermannallee 1, D-50829 Köln, Germany. Fax: +49 221 8887 111. Website: http://www.direvo.com (26 Nov 2002)
Engelhard 3Q 2002 results: Environmental Technologies Operating earnings from Engelhard Corp’s Environmental Technologies declined 43% in 3Q 2002 to $20 M. Sales increased 6% to $158 M as increased revenue from the automotive market was partly offset by lower demand from the powergeneration market. Earnings declined
JANUARY 2003
O N
C ATA LY S T S
in comparison with unusually strong results in 3Q 2001, combined with significantly higher costs in 3Q 2002 resulting primarily from higher manufacturing costs, including rework for power-generation applications, plus 2002’s increased development and startup costs related to new technologies for diesel engines. Engelhard 3Q 2002 Report, 24 Oct 2002, 2 (Engelhard Corp, Iselin, NJ, USA, Website: http://www.engelhard.com)
Engelhard 3Q 2002 results: Process Technologies Operating earnings from Engelhard Corp’s Process Technologies declined 13% in 3Q 2002 to $21 M. Sales were $126 M, down from $131 M in 3Q 2001. Sales continued to be impacted by lower volumes in some chemical markets and lower precious metals prices, which are passed through to customers. Strong results from refining, polyolefins, and gas-toliquids markets, driven by demand for new products, were offset by weak demand in other core chemical process markets. Engelhard 3Q 2002 Report, 24 Oct 2002, 2 (Engelhard Corp, Iselin, NJ, USA, Website: http://www.engelhard.com)
INEOS Silicas Netherlands: short profile A short profile is presented of INEOS Silicas Netherlands BV (formerly Crosfield BV), part of Ineos Silicas, which has facilities throughout the world. Ineos Silicas employs around 900 workers, with around 170 workers based at Eijsden in The Netherlands, where more than 160,000 tonne/y silicates and zeolites are produced. These are prepared from raw materials such as sand, soda, soda lye, and aluminium hydroxide. Open Dag Chemie, 2 Nov 2002, 22 (VNCI (Association of the Dutch Chemical Industry), Vlietweg 16, Leidschendam, PO Box 443, 2260 AK Leidschendam, The Netherlands. Tel: +31 70 337 87 33. Fax: +31 70 320 84 38. Website: http://www.vnci.nl) (in Dutch)
Johnson Matthey Fuel Cells Ltd On 8 Nov 2002 Johnson Matthey announced that Anglo Platinum has taken a 17.5% stake in its fuel cell components subsidiary, Johnson Matthey Fuel Cells Ltd. Johnson Matthey and Anglo Platinum have for
many years collaborated on R&D into fuel cell components and enabling technologies, under a long-term agreement announced in May 1993. Anglo Platinum has agreed to contribute its share of the intellectual property rights and know-how which has been developed under that agreement, together with a £20 M payment, in return for the 17.5% stake in the new company. Johnson Matthey Fuel Cells Ltd will manufacture and market all the fuel cell components currently being developed by Johnson Matthey including membrane electrode assemblies, fuel processors, and fuel cell catalysts. It will continue to be managed as part of the Johnson Matthey group and purchase services from other parts of the group. The relationship with Anglo Platinum will also give the fuel cell business improved access to future platinum supplies. Press release from Johnson Matthey plc, UK. Website: http://www.matthey.com (8 Nov 2002) & Chemical Week, 20-27 Nov 2002, 164 (46), 16 & Chimie Hebdo, 18 Nov 2002, (192), 14 (in French)
Neozyme International enters into distribution agreement in NY Neozyme International Inc has recently signed a Distribution Agreement for the representation of its patented bio-organic catalysts within the state of New York. The primary focus will centre on EcoZyme, a Neozyme product that has proven very effective in eliminating the buildup of fats, oils, and greases (FOG) in all manner of collection systems, from residential and commercial plumbing drains to municipal sewers and lift stations. Press release from International Daleco Corp, 33 Journey, Aliso Viejo, CA 92656, USA. Tel: +1 949 360 4288 or +1 800 432 5326. Fax: +1 949 360 8774. Website: http://www.daleco.com (21 Nov 2002)
Novozymes results for Jan-Sep 2002 Novozymes A/S reported results for nine months of 2002. Net turnover increased by 8% to DKR 4190 M for nine months of 2002 (DKR 3882 M in nine months of 2001). Volumes, prices, and product mix in the market increased sales by 11% in nine months of 2002. Profit after taxation was DKR 452 M for nine months of
3
Danisco and Direvo sign enzyme development collaboration Direvo Biotech AG (Direvo) and Danisco A/S announced the signing of a collaboration agreement under which both parties will develop an industrial enzyme. Under the terms of the agreement, Danisco will obtain worldwide exclusive rights to commercialize the products developed under this collaboration. In return, Direvo will receive R&D funding, milestone payments, and royalties on future product sales. Direvo Biotech AG, based in Cologne, is a leading company in screeningbased directed evolution and applies its integrated proprietary technologies to the development of better biopharmaceuticals and improved industrial enzymes. Danisco A/S develops and produces functional ingredients, sweeteners, and sugar. Press release from Direvo Biotech AG, Nattermannallee 1, D-50829 Köln, Germany. Fax: +49 221 8887 111. Website: http://www.direvo.com (26 Nov 2002)
Engelhard 3Q 2002 results: Environmental Technologies Operating earnings from Engelhard Corp’s Environmental Technologies declined 43% in 3Q 2002 to $20 M. Sales increased 6% to $158 M as increased revenue from the automotive market was partly offset by lower demand from the powergeneration market. Earnings declined
JANUARY 2003
O N
C ATA LY S T S
in comparison with unusually strong results in 3Q 2001, combined with significantly higher costs in 3Q 2002 resulting primarily from higher manufacturing costs, including rework for power-generation applications, plus 2002’s increased development and startup costs related to new technologies for diesel engines. Engelhard 3Q 2002 Report, 24 Oct 2002, 2 (Engelhard Corp, Iselin, NJ, USA, Website: http://www.engelhard.com)
Engelhard 3Q 2002 results: Process Technologies Operating earnings from Engelhard Corp’s Process Technologies declined 13% in 3Q 2002 to $21 M. Sales were $126 M, down from $131 M in 3Q 2001. Sales continued to be impacted by lower volumes in some chemical markets and lower precious metals prices, which are passed through to customers. Strong results from refining, polyolefins, and gas-toliquids markets, driven by demand for new products, were offset by weak demand in other core chemical process markets. Engelhard 3Q 2002 Report, 24 Oct 2002, 2 (Engelhard Corp, Iselin, NJ, USA, Website: http://www.engelhard.com)
INEOS Silicas Netherlands: short profile A short profile is presented of INEOS Silicas Netherlands BV (formerly Crosfield BV), part of Ineos Silicas, which has facilities throughout the world. Ineos Silicas employs around 900 workers, with around 170 workers based at Eijsden in The Netherlands, where more than 160,000 tonne/y silicates and zeolites are produced. These are prepared from raw materials such as sand, soda, soda lye, and aluminium hydroxide. Open Dag Chemie, 2 Nov 2002, 22 (VNCI (Association of the Dutch Chemical Industry), Vlietweg 16, Leidschendam, PO Box 443, 2260 AK Leidschendam, The Netherlands. Tel: +31 70 337 87 33. Fax: +31 70 320 84 38. Website: http://www.vnci.nl) (in Dutch)
Johnson Matthey Fuel Cells Ltd On 8 Nov 2002 Johnson Matthey announced that Anglo Platinum has taken a 17.5% stake in its fuel cell components subsidiary, Johnson Matthey Fuel Cells Ltd. Johnson Matthey and Anglo Platinum have for
many years collaborated on R&D into fuel cell components and enabling technologies, under a long-term agreement announced in May 1993. Anglo Platinum has agreed to contribute its share of the intellectual property rights and know-how which has been developed under that agreement, together with a £20 M payment, in return for the 17.5% stake in the new company. Johnson Matthey Fuel Cells Ltd will manufacture and market all the fuel cell components currently being developed by Johnson Matthey including membrane electrode assemblies, fuel processors, and fuel cell catalysts. It will continue to be managed as part of the Johnson Matthey group and purchase services from other parts of the group. The relationship with Anglo Platinum will also give the fuel cell business improved access to future platinum supplies. Press release from Johnson Matthey plc, UK. Website: http://www.matthey.com (8 Nov 2002) & Chemical Week, 20-27 Nov 2002, 164 (46), 16 & Chimie Hebdo, 18 Nov 2002, (192), 14 (in French)
Neozyme International enters into distribution agreement in NY Neozyme International Inc has recently signed a Distribution Agreement for the representation of its patented bio-organic catalysts within the state of New York. The primary focus will centre on EcoZyme, a Neozyme product that has proven very effective in eliminating the buildup of fats, oils, and greases (FOG) in all manner of collection systems, from residential and commercial plumbing drains to municipal sewers and lift stations. Press release from International Daleco Corp, 33 Journey, Aliso Viejo, CA 92656, USA. Tel: +1 949 360 4288 or +1 800 432 5326. Fax: +1 949 360 8774. Website: http://www.daleco.com (21 Nov 2002)
Novozymes results for Jan-Sep 2002 Novozymes A/S reported results for nine months of 2002. Net turnover increased by 8% to DKR 4190 M for nine months of 2002 (DKR 3882 M in nine months of 2001). Volumes, prices, and product mix in the market increased sales by 11% in nine months of 2002. Profit after taxation was DKR 452 M for nine months of
3